BW Communities

Articles for Pharma

Activists, Drug Groups Split Over Suspending COVID-19 Shot Patents

The idea seems simple, but some experts say it's not so clear cut. Below we lay out the reasons.

Read More
Natco's Marketing Partner Gets USFDA Nod For Cancer Treatment Drug

Natco's partner BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks.

Read More
Disruptions And Pharma-Nutra Business Opportunities For 2021-22

Digital transformation in the pharmaceutical industry was already there even before COVID-19, but in the pandemic time this shook the Healthcare world to its foundations.

Read More
Delhi CM administered COVID-19 vaccine at LNJP hospital

The Covishield vaccine was first administered to Kejriwal's parents, Govind Ram Kejriwal and Gita Devi, and then to the chief minister.

Read More
COVID-19 Vaccine Shows 81% Interim Clinical Efficacy, Says Bharat Biotech

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research.

Read More
AstraZeneca Has Sold Its Stake In Moderna For More Than $1 billion

The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.

Read More
I'm Sure Global Pharma Industry Will Support India's WTO Proposal Of IP Waiver For COVID-19: Goyal

The agreement on Trade-Related Aspects of Intellectual Property Rights or TRIPS came into effect in January 1995. It is a multilateral agreement on intellectual property (IP) rights such as copyright, industrial designs, patents and protection of undisclosed information or trade secrets.

Read More
Cadila Healthcare Stocks Rise Over 2%

The pharmaceutical company's stocks were trading 1.98 per cent higher at Rs 442.50 on the BSE.

Read More
Cabinet Approves PLI Scheme For Pharmaceuticals

The PLI scheme for pharma is expected to promote the production of high-value products in the country and increase the value addition in exports.

Read More
AstraZeneca To Miss Second-quarter EU Vaccine Supply Target By Half - EU official

AstraZeneca did not deny what the official said, but a statement late in the day said the company was striving to increase productivity to deliver the promised 180 million doses.

Read More

Subscribe to our newsletter to get updates on our latest news